ExCellThera
PrivateLast Round
Grant
Sep 20, 2022
Total Funding Raised
$620,000
Momentum
Top 5%
of companies Caplight tracks
Company Overview
ExCellThera is a biotechnology company that develops and commercializes advanced cell expansion and engineering solutions for the treatment of blood cancers and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ExCellThera Comparables
Compare ExCellThera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nohla Therapeutics | 83% | |
| Celaid Therapeutics | 79% | |
| HexemBio | 79% |
ExCellThera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 20, 2022 | ||||
| Grant | Aug 7, 2020 | ||||
| Grant | Apr 5, 2017 | ||||
| Accelerator | Jun 15, 2015 |
Key People
Founding team and executive leadership
ExCellThera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IRICoR | Grant, Accelerator |
| CCRM | Accelerator |
| California Institute for Regenerative Medicine | Grant |
| Next Generation Manufacturing Canada (NGen) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 67% MoM.
- Aug 21, 2026
Monthly visitors grew 79% MoM, reaching 1.7K.
ExCellThera Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ExCellThera's valuation, stock price, and market status.
Is ExCellThera a public or private company?
ExCellThera is a private company.
What is the current stock price of ExCellThera?
ExCellThera is a private company, so its shares have no public market price. Caplight tracks ExCellThera's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ExCellThera worth (valuation)?
Valuation information for ExCellThera is not publicly available.
Can I buy ExCellThera stock?
ExCellThera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ExCellThera's last funding round?
ExCellThera's most recent funding round was Grant on September 20, 2022.
Who are the main investors in ExCellThera?
Key investors in ExCellThera include IRICoR, CCRM, California Institute for Regenerative Medicine, Next Generation Manufacturing Canada (NGen).
Will ExCellThera IPO soon?
No public IPO plans have been announced for ExCellThera.
How can I track ExCellThera secondary market activity?
Caplight tracks bids, offers, and trades in ExCellThera's shares on secondary markets.